65
JHL Biotech
6540.TW·TWSEHsinchu TWFounded 2014500 employees
Small CapbiotechPublicOncology
Platform: Biosimilar CDMO
Market Cap
$0.3B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (6540.TW)
Loading 6540.TW stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Kemazumab | 654-9785 | Approved | 2 | BCMA | NSCLC | ||
| Motamavacamten | 654-1004 | Phase 3 | 2 | BTK | HSRSV |
SEC Filings & Financial Documents
SEC filings are not available for TWSE-listed companies.
JHL Biotech trades on TWSE (TW). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)